bioRxiv Science⌕ Search

Biology subjects

Bullers, S.

Publications and source records attributed to Bullers, S..

4 recordsLinked to original sources

Machine Learning Predictions Surpass Individual mRNAs as a Proxy of Single-cell Protein Expression

BackgroundExpansive repositories of single-cell RNA-seq data are now available. These data are often analysed assuming that mRNA abundance reflects the expression of their cognate proteins. However, post-transcriptional and translational regulation make mRNA an inadequate proxy for protein. High sparsity in low abundance mRNAs from single-cell transcriptomics data further complicates the extrapolation of protein expression levels. Although methods for single-cell surface protein quantification exist, they incur additional technical steps at greater expense and have yet to see wide-spread adoption. Computational approaches for protein imputation from scRNAseq data have been published, which learn transcriptome-wide patterns that predict protein expression. These models can then be applied to infer surface protein expression on RNA-seq only data, to increase the utility of existing data repositories. ResultsWe tested 8 such methods and compared the accuracy of predictions between approaches, and against cognate mRNAs as a direct proxy. Predictions from the trained models outperformed the use of mRNA expression as a proxy. We identify notable cases of cell surface proteins with very poor correlation with their mRNA that were predicted very successfully by imputation using the whole transcriptome. We find cell type signatures are a major determinant of predicted protein levels and, as such, prediction methods require representative training data. ConclusionsThese results reiterate that mRNA level is not a reliable predictor of cell surface protein expression, and that whole-transcriptome informed imputation can improve protein estimations given appropriately trained models.

bioinformatics↗

A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and mice

Interactions with commensal microbes shape host immunity on multiple levels and are recognized to play a pivotal role in human health and disease. In this study, we show that MHC-II restricted, commensal-reactive T cells in the colon of both humans and mice acquire transcriptional and functional characteristics typically associated with innate-like T cells, including the expression of the key transcription factor PLZF and the ability to respond to cytokines including IL-12, IL-18 and IL-23 in a TCR-independent manner. These MHC-II restricted, innate-like, commensal-reactive T cells (TMIC) are endowed with a polyfunctional effector potential spanning classic Th1- and Th17-cytokines, cytotoxic molecules as well as regulators of epithelial homeostasis and represent an abundant and conserved cell population in the human and murine colon. T cells with the TMIC phenotype were increased in ulcerative colitis patients and their presence aggravated pathology in DSS-treated mice, pointing towards a pathogenic role in colitis. Our findings add TMIC cells to the expanding spectrum of innate-like immune cells positioned at the frontline of intestinal immune surveillance, capable of acting as sentinels of microbes and the local cytokine milieu.

immunology↗

IL-1-driven stromal-neutrophil interaction in deep ulcers defines a pathotype of therapy non-responsive inflammatory bowel disease

Current inflammatory bowel disease (IBD) therapies are ineffective in a high proportion of patients. Combining bulk and single-cell transcriptomics, quantitative histopathology, and in situ localisation, we describe heterogeneity of the tissular inflammatory response in IBD treatment failure. Among inflammatory pathotypes, we found high neutrophil infiltration, activation of fibroblasts, and vascular remodelling at sites of deep ulceration was a feature of non-response to several anti-inflammatory therapies. Activated fibroblasts in the ulcer bed display neutrophil chemoattractant properties that are IL-1R- but not TNF-dependent. The identification of distinct, localised, tissular pathotypes associated with treatment non-response will aid precision targeting of current therapeutics and provide a biological rationale for IL-1 signalling blockade in ulcerating disease.

immunology↗

PYK2 controls intestinal inflammation via activation of IRF5 in macrophages

Inflammatory bowel disease (IBD) is a group of inflammatory disorders of the gastro-intestinal tract caused by a complex combination of genetic and environmental factors. Interferon regulating factor 5 (IRF5) is a multifunctional regulator of immune responses, which plays a key pathogenic role in mouse colitis models and is a genetic risk factor for IBD. A screen of a protein kinase inhibitor library in macrophages revealed a list of putative IRF5 kinases. Among the top hits validated in multiple in vitro assays, protein-tyrosine kinase 2-beta (PTK2B or PYK2) was identified as the only IBD genetic risk factor, known to impact gene expression in myeloid cells1,2. Phospho-proteomics and mutagenesis analyses established that PYK2 directly phosphorylates and activates IRF5 at tyrosine (Y) 171. IRF5 nuclear translocation and recruitment to target genes was impaired in PYK2-deficient cells or in cells treated with PYK2 inhibitors. Importantly, macrophage transcriptomic signature under PYK2 inhibition phenocopied IRF5 deficiency. Treatment with a PYK2 inhibitor reduced pathology and inflammatory cytokine production in Helicobacter hepaticus + anti-IL-10R antibody induced colitis model. It also decreased levels of pro-inflammatory cytokines in human colon biopsies taken from patients with ulcerative colitis. Thus, we have identified a major role for PYK2 in regulating the inflammatory response and mapped its activity to the IRF5 innate sensing pathway, opening opportunities for therapeutic interference with it in IBD and other inflammatory conditions.

immunology↗